Reference : A 2-year phase II study with 1-year of follow-up of risedronate (NE58095) in postmeno...
Scientific journals : Article
Human health sciences : General & internal medicine
http://hdl.handle.net/2268/136095
A 2-year phase II study with 1-year of follow-up of risedronate (NE58095) in postmenopausal osteoporosis
English
Clemmesen, B []
Ravn, P []
Zegels, Brigitte [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Taquet, AN []
Christiansen, C []
Reginster, Jean-Yves mailto [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
1997
Osteoporosis International
Springer Science & Business Media B.V.
7
488-495
Yes (verified by ORBi)
International
0937-941X
1433-2965
Godalming
United Kingdom
http://hdl.handle.net/2268/136095

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
A 2-year phase II study with 1-year of follow-up of risedronate in postmenopausal osteoporosis.pdfPublisher postprint741.07 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.